Do analysts prefer SERA or CCM?

Sera Prognostics presently has a consensus target price of $5.50, suggesting a potential upside of 175.00%. Given Sera Prognostics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Sera Prognostics is more favorable than Concord Medical Services. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sera Prognostics 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67 Concord Medical Services 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings and valuation, SERA or CCM?

Concord Medical Services has higher revenue and earnings than Sera Prognostics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sera Prognostics $80K 979.00 -$31.93M -$0.65 N/A Concord Medical Services $460.51M 0.04 -$13.27M N/A N/A

Does the media refer more to SERA or CCM?

In the previous week, Sera Prognostics had 1 more articles in the media than Concord Medical Services. MarketBeat recorded 2 mentions for Sera Prognostics and 1 mentions for Concord Medical Services. Sera Prognostics' average media sentiment score of 0.00 equaled Concord Medical Services'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sera Prognostics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Concord Medical Services 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate NAKA or CCM?

KindlyMD currently has a consensus target price of $30.00, indicating a potential upside of 677.20%. Given KindlyMD's stronger consensus rating and higher probable upside, analysts clearly believe KindlyMD is more favorable than Concord Medical Services. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score KindlyMD 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Concord Medical Services 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings and valuation, NAKA or CCM?

Concord Medical Services has higher revenue and earnings than KindlyMD. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio KindlyMD $1.82M 36.90 -$52.23M -$43.20 N/A Concord Medical Services $460.51M 0.04 -$13.27M N/A N/A

Does the media refer more to NAKA or CCM?

In the previous week, KindlyMD and KindlyMD both had 1 articles in the media. KindlyMD's average media sentiment score of 0.00 equaled Concord Medical Services'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KindlyMD 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Concord Medical Services 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer DCGO or CCM?

DocGo presently has a consensus price target of $2.38, indicating a potential upside of 327.47%. Given DocGo's stronger consensus rating and higher probable upside, research analysts clearly believe DocGo is more favorable than Concord Medical Services. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DocGo 1 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33 Concord Medical Services 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, DCGO or CCM?

Concord Medical Services has higher revenue and earnings than DocGo. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DocGo $322.20M 0.17 -$182.40M -$1.91 N/A Concord Medical Services $460.51M 0.04 -$13.27M N/A N/A

Does the media prefer DCGO or CCM?

In the previous week, DocGo had 1 more articles in the media than Concord Medical Services. MarketBeat recorded 2 mentions for DocGo and 1 mentions for Concord Medical Services. DocGo's average media sentiment score of 0.40 beat Concord Medical Services' score of 0.00 indicating that DocGo is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DocGo 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Concord Medical Services 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate EUDA or CCM?

EUDA Health presently has a consensus price target of $55.00, suggesting a potential upside of 296.25%. Given EUDA Health's stronger consensus rating and higher possible upside, research analysts plainly believe EUDA Health is more favorable than Concord Medical Services. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score EUDA Health 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Concord Medical Services 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings & valuation, EUDA or CCM?

EUDA Health has higher earnings, but lower revenue than Concord Medical Services. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio EUDA Health $6.82M 6.09 -$2.77M -$2.40 N/A Concord Medical Services $460.51M 0.04 -$13.27M N/A N/A

Is EUDA or CCM more profitable?

Company Net Margins Return on Equity Return on Assets EUDA Health N/A N/A N/A Concord Medical Services N/A N/A N/A

Do analysts rate MRAI or CCM?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Marpai 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Concord Medical Services 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings and valuation, MRAI or CCM?

Concord Medical Services has higher revenue and earnings than Marpai. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Marpai $34.87M 0.54 -$28.75M -$0.87 N/A Concord Medical Services $460.51M 0.04 -$13.27M N/A N/A

Is MRAI or CCM more profitable?

Concord Medical Services has a net margin of 0.00% compared to Marpai's net margin of -85.70%. Company Net Margins Return on Equity Return on Assets Marpai -85.70% N/A -100.23% Concord Medical Services N/A N/A N/A

Concord Medical Services (CCM) Competitors

$4.39 0.00 (0.00%)

Closing price 07/2/2026 03:59 PM Eastern

Extended Trading

$4.45 +0.06 (+1.37%)

As of 07/2/2026 04:02 PM Eastern

Compare

CCM vs. SERA, NAKA, DCGO, EUDA, and MRAI

Should you buy Concord Medical Services stock or one of its competitors? MarketBeat compares Concord Medical Services with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Concord Medical Services include Sera Prognostics (SERA), KindlyMD (NAKA), DocGo (DCGO), EUDA Health (EUDA), and Marpai (MRAI). These companies are all part of the "healthcare" industry.

How does Concord Medical Services compare to Sera Prognostics?

Sera Prognostics (NASDAQ:SERA) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, media sentiment, valuation, analyst recommendations, risk and institutional ownership.

Concord Medical Services has a net margin of 0.00% compared to Sera Prognostics' net margin of -56,385.97%. Concord Medical Services' return on equity of 0.00% beat Sera Prognostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sera Prognostics	-56,385.97%	-41.02%	-30.95%
Concord Medical Services	N/A	N/A	N/A

54.6% of Sera Prognostics shares are held by institutional investors. 11.3% of Sera Prognostics shares are held by insiders. Comparatively, 46.5% of Concord Medical Services shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Sera Prognostics had 1 more articles in the media than Concord Medical Services. MarketBeat recorded 2 mentions for Sera Prognostics and 1 mentions for Concord Medical Services. Sera Prognostics' average media sentiment score of 0.00 equaled Concord Medical Services'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sera Prognostics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Concord Medical Services	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Sera Prognostics presently has a consensus target price of $5.50, suggesting a potential upside of 175.00%. Given Sera Prognostics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Sera Prognostics is more favorable than Concord Medical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sera Prognostics	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Concord Medical Services has higher revenue and earnings than Sera Prognostics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sera Prognostics	$80K	979.00	-$31.93M	-$0.65	N/A
Concord Medical Services	$460.51M	0.04	-$13.27M	N/A	N/A

Sera Prognostics has a beta of 0.97, meaning that its stock price is 3% less volatile than the broader market. Comparatively, Concord Medical Services has a beta of -0.97, meaning that its stock price is 197% less volatile than the broader market.

Summary

Sera Prognostics beats Concord Medical Services on 8 of the 14 factors compared between the two stocks.

How does Concord Medical Services compare to KindlyMD?

KindlyMD (NASDAQ:NAKA) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, risk, profitability, media sentiment and valuation.

Concord Medical Services has a net margin of 0.00% compared to KindlyMD's net margin of -7,397.12%. Concord Medical Services' return on equity of 0.00% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KindlyMD	-7,397.12%	-81.32%	-54.17%
Concord Medical Services	N/A	N/A	N/A

In the previous week, KindlyMD and KindlyMD both had 1 articles in the media. KindlyMD's average media sentiment score of 0.00 equaled Concord Medical Services'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
KindlyMD	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Concord Medical Services	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

KindlyMD currently has a consensus target price of $30.00, indicating a potential upside of 677.20%. Given KindlyMD's stronger consensus rating and higher probable upside, analysts clearly believe KindlyMD is more favorable than Concord Medical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Concord Medical Services has higher revenue and earnings than KindlyMD.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KindlyMD	$1.82M	36.90	-$52.23M	-$43.20	N/A
Concord Medical Services	$460.51M	0.04	-$13.27M	N/A	N/A

KindlyMD has a beta of 16.05, indicating that its stock price is 1,505% more volatile than the broader market. Comparatively, Concord Medical Services has a beta of -0.97, indicating that its stock price is 197% less volatile than the broader market.

Summary

KindlyMD and Concord Medical Services tied by winning 5 of the 10 factors compared between the two stocks.

How does Concord Medical Services compare to DocGo?

DocGo (NASDAQ:DCGO) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, valuation, risk, media sentiment, dividends and analyst recommendations.

DocGo presently has a consensus price target of $2.38, indicating a potential upside of 327.47%. Given DocGo's stronger consensus rating and higher probable upside, research analysts clearly believe DocGo is more favorable than Concord Medical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DocGo	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

56.4% of DocGo shares are owned by institutional investors. 3.8% of DocGo shares are owned by insiders. Comparatively, 46.5% of Concord Medical Services shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

DocGo has a beta of 1.02, suggesting that its stock price is 2% more volatile than the broader market. Comparatively, Concord Medical Services has a beta of -0.97, suggesting that its stock price is 197% less volatile than the broader market.

Concord Medical Services has a net margin of 0.00% compared to DocGo's net margin of -62.23%. Concord Medical Services' return on equity of 0.00% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DocGo	-62.23%	-44.09%	-29.14%
Concord Medical Services	N/A	N/A	N/A

In the previous week, DocGo had 1 more articles in the media than Concord Medical Services. MarketBeat recorded 2 mentions for DocGo and 1 mentions for Concord Medical Services. DocGo's average media sentiment score of 0.40 beat Concord Medical Services' score of 0.00 indicating that DocGo is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DocGo	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Concord Medical Services	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Concord Medical Services has higher revenue and earnings than DocGo.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DocGo	$322.20M	0.17	-$182.40M	-$1.91	N/A
Concord Medical Services	$460.51M	0.04	-$13.27M	N/A	N/A

Summary

DocGo beats Concord Medical Services on 8 of the 14 factors compared between the two stocks.

How does Concord Medical Services compare to EUDA Health?

EUDA Health (NASDAQ:EUDA) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk.

EUDA Health presently has a consensus price target of $55.00, suggesting a potential upside of 296.25%. Given EUDA Health's stronger consensus rating and higher possible upside, research analysts plainly believe EUDA Health is more favorable than Concord Medical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

4.4% of EUDA Health shares are owned by institutional investors. 46.5% of Concord Medical Services shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

EUDA Health has higher earnings, but lower revenue than Concord Medical Services.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EUDA Health	$6.82M	6.09	-$2.77M	-$2.40	N/A
Concord Medical Services	$460.51M	0.04	-$13.27M	N/A	N/A

EUDA Health has a beta of 0.68, indicating that its share price is 32% less volatile than the broader market. Comparatively, Concord Medical Services has a beta of -0.97, indicating that its share price is 197% less volatile than the broader market.

In the previous week, Concord Medical Services had 1 more articles in the media than EUDA Health. MarketBeat recorded 1 mentions for Concord Medical Services and 0 mentions for EUDA Health. EUDA Health's average media sentiment score of 0.00 equaled Concord Medical Services'average media sentiment score.

Company	Overall Sentiment
EUDA Health	Neutral
Concord Medical Services	Neutral

Company	Net Margins	Return on Equity	Return on Assets
EUDA Health	N/A	N/A	N/A
Concord Medical Services	N/A	N/A	N/A

Summary

EUDA Health beats Concord Medical Services on 7 of the 10 factors compared between the two stocks.

How does Concord Medical Services compare to Marpai?

Marpai (NASDAQ:MRAI) and Concord Medical Services (NYSE:CCM) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, media sentiment, analyst recommendations, earnings and risk.

Marpai has a beta of 4.92, meaning that its stock price is 392% more volatile than the broader market. Comparatively, Concord Medical Services has a beta of -0.97, meaning that its stock price is 197% less volatile than the broader market.

49.8% of Marpai shares are owned by institutional investors. 46.1% of Marpai shares are owned by company insiders. Comparatively, 46.5% of Concord Medical Services shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Concord Medical Services has higher revenue and earnings than Marpai.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Marpai	$34.87M	0.54	-$28.75M	-$0.87	N/A
Concord Medical Services	$460.51M	0.04	-$13.27M	N/A	N/A

In the previous week, Concord Medical Services had 1 more articles in the media than Marpai. MarketBeat recorded 1 mentions for Concord Medical Services and 0 mentions for Marpai. Marpai's average media sentiment score of 0.00 equaled Concord Medical Services'average media sentiment score.

Company	Overall Sentiment
Marpai	Neutral
Concord Medical Services	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Marpai	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Concord Medical Services has a net margin of 0.00% compared to Marpai's net margin of -85.70%.

Company	Net Margins	Return on Equity	Return on Assets
Marpai	-85.70%	N/A	-100.23%
Concord Medical Services	N/A	N/A	N/A

Summary

Concord Medical Services beats Marpai on 7 of the 10 factors compared between the two stocks.

Get Concord Medical Services News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CCM vs. The Competition

Export

Metric	Concord Medical Services	MED Industry	Medical Sector	NYSE Exchange
Market Cap	$19.06M	$4.26B	$7.18B	$23.53B
Dividend Yield	N/A	0.69%	2.66%	3.98%
P/E Ratio	N/A	13.79	28.02	31.55
Price / Sales	0.04	1.36	538.82	21.79
Price / Cash	2.36	20.58	49.26	25.36
Price / Book	0.07	2.53	10.96	4.81
Net Income	-$13.27M	$47.01M	$3.57B	$1.07B
7 Day Performance	-6.40%	0.97%	2.12%	0.56%
1 Month Performance	-7.31%	8.48%	5.25%	4.54%
1 Year Performance	-26.21%	54.88%	33.29%	18.23%

Concord Medical Services Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CCM Concord Medical Services	0.3065 of 5 stars	$4.39 flat	N/A	-26.2%	$19.06M	$460.51M	N/A	970	News Coverage Gap Up
SERA Sera Prognostics	2.8856 of 5 stars	$1.80 -2.2%	$5.50 +205.6%	-19.8%	$72.05M	$80K	N/A	120	News Coverage
NAKA KindlyMD	3.4756 of 5 stars	$4.05 +3.6%	$30.00 +640.7%	-99.2%	$68.04M	$1.82M	N/A	N/A	Gap Up
DCGO DocGo	2.9938 of 5 stars	$0.50 -0.4%	$2.38 +370.8%	-64.9%	$50.04M	$322.20M	N/A	3,568	News Coverage High Trading Volume
EUDA EUDA Health	2.4588 of 5 stars	$14.90 +4.2%	$55.00 +269.1%	-79.5%	$42.82M	$6.82M	N/A	2	Short Interest Decrease Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CCM) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Concord Medical Services (CCM) Competitors

CCM vs. SERA, NAKA, DCGO, EUDA, and MRAI

How does Concord Medical Services compare to Sera Prognostics?

Summary

How does Concord Medical Services compare to KindlyMD?

Summary

How does Concord Medical Services compare to DocGo?

Summary

How does Concord Medical Services compare to EUDA Health?

Summary

How does Concord Medical Services compare to Marpai?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCM vs. The Competition

Concord Medical Services Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Concord Medical Services (CCM) Competitors

CCM vs. SERA, NAKA, DCGO, EUDA, and MRAI

How does Concord Medical Services compare to Sera Prognostics?

Is SERA or CCM more profitable?

Do institutionals and insiders have more ownership in SERA or CCM?

Does the media refer more to SERA or CCM?

Do analysts prefer SERA or CCM?

Which has stronger earnings and valuation, SERA or CCM?

Which has more risk and volatility, SERA or CCM?

Summary

How does Concord Medical Services compare to KindlyMD?

Is NAKA or CCM more profitable?

Does the media refer more to NAKA or CCM?

Do analysts rate NAKA or CCM?

Which has higher earnings and valuation, NAKA or CCM?

Which has more risk & volatility, NAKA or CCM?

Summary

How does Concord Medical Services compare to DocGo?

Do analysts prefer DCGO or CCM?

Do institutionals & insiders believe in DCGO or CCM?

Which has more volatility & risk, DCGO or CCM?

Is DCGO or CCM more profitable?

Does the media prefer DCGO or CCM?

Which has preferable valuation & earnings, DCGO or CCM?

Summary

How does Concord Medical Services compare to EUDA Health?

Do analysts rate EUDA or CCM?

Do institutionals and insiders hold more shares of EUDA or CCM?

Which has better earnings & valuation, EUDA or CCM?

Which has more volatility & risk, EUDA or CCM?

Does the media refer more to EUDA or CCM?

Is EUDA or CCM more profitable?

Summary

How does Concord Medical Services compare to Marpai?

Which has more risk & volatility, MRAI or CCM?

Do insiders & institutionals believe in MRAI or CCM?

Which has stronger earnings and valuation, MRAI or CCM?

Does the media favor MRAI or CCM?

Do analysts rate MRAI or CCM?

Is MRAI or CCM more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCM vs. The Competition

Concord Medical Services Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools